Melanoma: the role of surgery in the era of new therapies

by Mozzillo, Nicola, Ascierto, Paolo A
Published 2014

Immunological effects of BRAF+MEK inhibition

by Ascierto, Paolo A., Dummer, Reinhard
Published in Oncoimmunology (2018)

Adjuvant therapy of melanoma with interferon: lessons of the past decade

by Ascierto, Paolo A, Kirkwood, John M
Published 2008

Combination therapy: the next opportunity and challenge of medicine

by Ascierto, Paolo A, Marincola, Francesco M
Published 2011

What have we learned from cancer immunotherapy in the last 3 years?

by Ascierto, Paolo A, Marincola, Francesco M
Published 2014

2015: The Year of Anti-PD-1/PD-L1s Against Melanoma and Beyond

by Ascierto, Paolo A., Marincola, Francesco M.
Published in EBioMedicine (2015)

Checkpoint inhibitors in melanoma and early phase development in solid tumors: what’s the future?

by Ascierto, Paolo A., McArthur, Grant A.
Published in J Transl Med (2017)

What is changing in the adjuvant treatment of melanoma?

by Ascierto, Paolo A., Palmieri, Giuseppe, Gogas, Helen
Published in Oncotarget (2017)

Melanoma: A model for testing new agents in combination therapies

by Ascierto, Paolo A, Streicher, Howard Z, Sznol, Mario
Published 2010

Anti-CTLA4 monoclonal antibodies: the past and the future in clinical application

by Ascierto, Paolo A, Marincola, Francesco M, Ribas, Antoni
Published 2011

Therapeutic Advancements Across Clinical Stages in Melanoma, With a Focus on Targeted Immunotherapy

by Trojaniello, Claudia, Luke, Jason J., Ascierto, Paolo A.
Published in Front Oncol (2021)

What’s new in melanoma? Combination!

by Ascierto, Paolo A, Marincola, Francesco M, Atkins, Michael B
Published in J Transl Med (2015)

Melanoma: From Research to Treatment

by Ascierto, Paolo A., Kirkwood, John M., Marincola, Francesco M., Palmieri, Giuseppe
Published 2011

No time to die: the consensus immunoscore for predicting survival and response to chemotherapy of locally advanced colon cancer patients in a multicenter international study

by Ascierto, Paolo A., Marincola, Francesco M., Fox, Bernard A., Galon, Jérôme
Published in Oncoimmunology (2020)

The Role of Optical Radiations in Skin Cancer

by Ayala, Fabrizio, Palla, Marco, Di Trolio, Rossella, Mozzillo, Nicola, Ascierto, Paolo A.
Published 2013

Systematic review of the use of granulocyte–macrophage colony-stimulating factor in patients with advanced melanoma

by Hoeller, Christoph, Michielin, Olivier, Ascierto, Paolo A., Szabo, Zsolt, Blank, Christian U.
Published in Cancer Immunol Immunother (2016)

New‐generation anticancer drugs and medication‐related osteonecrosis of the jaw (MRONJ): Late onset 3 years after ipilimumab endovenous administration with a possible role of targe...

by Guida, Agostino, Perri, Francesco, Ionna, Franco, Ascierto, Paolo A., Grimaldi, Antonio M.
Published in Clin Case Rep (2020)

Overall survival of patients with chemotherapy-naive advanced melanoma treated with ipilimumab 3 mg/kg in clinical trials

by Dummer, Reinhard, Schadendorf, Dirk, Ascierto, Paolo A, Larkin, James, Lebbé, Celeste, Hauschild, Axel
Published 2014

Genetic instability and increased mutational load: which diagnostic tool best direct patients with cancer to immunotherapy?

by Palmieri, Giuseppe, Colombino, Maria, Cossu, Antonio, Marchetti, Antonio, Botti, Gerardo, Ascierto, Paolo A.
Published in J Transl Med (2017)

Sequencing of BRAF inhibitors and ipilimumab in patients with metastatic melanoma: a possible algorithm for clinical use

by Ascierto, Paolo A, Simeone, Ester, Giannarelli, Diana, Grimaldi, Antonio M, Romano, Anna, Mozzillo, Nicola
Published 2012